A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions*
暂无分享,去创建一个
S. Hazen | E. Podrez | Renliang Zhang | R. Silverstein | M. Febbraio | D. Hajjar | E. Poliakov | Mingjiang Sun | R. G. Salomon | H. Hoff | Zhongzhou Shen | Yijun Deng | Paula J Finton | L. Shan
[1] Yijun Deng,et al. Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36* , 2002, The Journal of Biological Chemistry.
[2] W. Sha,et al. Novel bioactive phospholipids: practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine(1). , 2002, The Journal of organic chemistry.
[3] E J Topol,et al. Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.
[4] M. Sinensky,et al. Mechanisms of oxysterol-induced apoptosis , 2001, Current opinion in lipidology.
[5] J. C. Hinshaw,et al. Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor γ Ligands and Agonists* , 2001, The Journal of Biological Chemistry.
[6] S. Yamashita,et al. CD36 deficiency associated with insulin resistance , 2001, The Lancet.
[7] T. Kita,et al. Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages* , 2000, The Journal of Biological Chemistry.
[8] S. Hazen,et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.
[9] S. Hazen,et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.
[10] E. Dennis,et al. The Binding of Oxidized Low Density Lipoprotein to Mouse CD36 Is Mediated in Part by Oxidized Phospholipids That Are Associated with Both the Lipid and Protein Moieties of the Lipoprotein* , 2000, The Journal of Biological Chemistry.
[11] N. Mackman,et al. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] K. Matsumoto,et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. , 1999, Circulation research.
[13] R. Silverstein,et al. A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.
[14] S. Hazen,et al. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.
[15] R. G. Salomon,et al. Total synthesis of γ-hydroxy-α,β-unsaturated aldehydic esters of cholesterol and 2-lysophosphatidylcholine , 1998 .
[16] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[17] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[18] D. Steinberg,et al. Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] Daniel Steinberg,et al. Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.
[20] David W. Dawson,et al. CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.
[21] L. Daviet,et al. Vascular Biology of CD36: Roles of this New Adhesion Molecule Family in Different Disease States , 1997, Thrombosis and Haemostasis.
[22] Wei Sha,et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.
[23] G. Chisolm,et al. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. , 1996, Journal of lipid research.
[24] L. Yesner,et al. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. , 1996, Blood.
[25] S. Yamashita,et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. , 1995, The Journal of clinical investigation.
[26] G. Hoppe,et al. Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. , 1994, The Journal of clinical investigation.
[27] H. Lodish,et al. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.
[28] L. Stanton,et al. CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.
[29] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[30] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[31] James Scott,et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats , 1999, Nature Genetics.
[32] E. Dennis,et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.